查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916570

全球生技原料市场：市场规模、占有率、成长率、产业分析、按类型、应用和地区划分的考量因素以及未来预测（2026-2034）

Biotech Ingredients Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

生技原料市场成长因素

预计2025年全球生技原料市场规模将达23.2亿美元，2026年将成长至25亿美元，到2034年将达45.4亿美元。市场成长的主要驱动力是製药、化妆品、食品饮料和农业等行业对生物技术生产方法的日益普及。北美地区凭藉先进的生物製造基础设施和高额研发投入，预计2025年将占45%的市场占有率，成为市场领导者。

生技原料的生产流程包括发酵、酵素合成、细胞培养、基因工程及合成生物学等。这些成分包括酵素、胺基酸、胜肽、维生素、益生菌和活性药物成分 (API)。与合成原料相比，生物技术原料具有更高的纯度、可持续性、可扩展性和一致性，这推动了其在受监管行业的应用。

市场成长驱动因素

关键驱动因素之一是消费品和工业领域对永续、清洁标籤成分的需求不断增长。在食品和饮料行业，生物技术衍生的酵素和益生菌有助于改善消化、延长保质期并满足清洁标籤要求。在化妆品产业，微生物衍生的透明质酸、胜肽和神经酰胺因其安全环保的来源而日益受到青睐。

在製药业，生技原料对于生物製剂、疫苗、单株抗体和重组蛋白的生产至关重要。癌症、糖尿病和自体免疫疾病等慢性病发病率的上升导致人们对生物疗法的依赖性增强，直接推高了对生物技术衍生活性成分 (API) 和辅料的需求。

市场限制因子

儘管成长前景强劲，但高昂的研发和生产成本仍是主要限制因素。生技原料的开发需要精密的实验室设施、经验丰富的科学家、漫长的研发週期以及严格的监管合规，尤其是对于药品级生产。发酵和细胞培养系统需要精确的环境控制，增加了营运成本。

监管审批耗时更长，尤其是对于生物製剂而言，安全性、可追溯性和验证至关重要。中小企业往往由于资金限製而难以扩大生产规模，这构成了市场准入和竞争力的障碍。

先进疗法和生物相似药驱动的市场机会

重磅生物製剂的专利到期正在加速生物相似药的研发，从而对发酵衍生蛋白、培养基和纯化试剂产生了强劲的需求。这一趋势在肿瘤和自体免疫疾病治疗领域尤为明显。

细胞疗法、基因疗法、CAR-T疗法和抗体药物偶联物等先进疗法也在全球不断扩展。这些疗法需要病毒载体、重组细胞因子和工程蛋白等特殊的生物技术成分，从而在受监管的医疗保健市场中创造了新的长期需求。

监管与地缘政治因素带来的市场挑战

监管的复杂性仍然是一项重大挑战。美国、欧洲和亚洲的审批框架各不相同，需要不同的文件、测试方案和环境评估。合成生物学和基因改造微生物菌株通常会受到额外的审查，从而延缓商业化进程。

地缘政治紧张局势和贸易保护主义也在影响原料供应链。关税、出口限制以及对中国和印度原材料供应的依赖，迫使製造商实现生产基地多元化，增加了资本支出和合规负担。

细分市场分析：依原料及应用划分

依原料划分

市场依原料分为动物源性、植物源性及微生物源性原料。

2024年，动物源性原料占主导地位，这主要得益于胶原蛋白、明胶和激素类化合物的高生物利用度，这些物质广泛应用于药品和营养补充剂中。

植物源原料市场正在成长，这得益于酵素辅助萃取技术的发展，以及素食需求和永续发展趋势的推动。

预计到2026年，微生物源原料市场将占全球市场占有率的约46%，这主要得益于精准发酵、基于CRISPR的菌株优化以及高产微生物合成技术的进步。

依应用领域划分

市场依应用领域可分为医药、食品饮料、个人护理及化妆品等领域。

预计到2026年，医药产业将占市场占有率的约45.60%，这主要得益于生物製剂、疫苗和重组活性药物成分（API）需求的成长。

由于对益生菌、酵素和功能性蛋白的需求增加，食品饮料产业也在扩张。

由于生物技术胜肽、透明质酸和植物胶原蛋白等成分被应用于皮肤修復和抗衰老产品中，个人护理和化妆品行业正在蓬勃发展。

2024年，食品和饮料产业约占市场占有率的15.8%。

区域展望

北美

北美仍是最大的区域市场，预计2025年将达到10.6亿美元，2026年将达到11.4亿美元。光是美国预计到2026年市场规模就将达到9亿美元，主要得益于对生物製造和清洁标籤化妆品的需求。

亚太地区

由于政府的大力支持和生物製造的扩张，亚太地区正在经历快速成长。

预计2026年，中国市场规模将达到2.1亿美元，印度将达到1.1亿美元，日本将达到5,000万美元，主要得益于製药生产和发酵技术的投资。

欧洲

欧洲受益于永续发展法规和强大的生物技术研究。预计到2026年，德国市场规模将达2.6亿美元，英国将达到1.1亿美元。

拉丁美洲与中东/非洲

成长主要由製药业的扩张和生物基化妆品成分的日益普及推动，尤其是在巴西和海湾国家。

竞争格局与产业趋势

主要参与者包括奇华顿（Givaudan）、Codex InBiotech Ingredients、Covallo、帝斯曼-芬美意（dsm-firmenich）、Abel、赢创工业集团（Evonik Industries）、默克集团（Merck KGaA）、Conagen、Fermenta Biotech和Titan Biotech。这些公司专注于扩大发酵产能、推出永续成分并建立策略合作伙伴关係。

预计2024年至2025年间的主要发展包括私募股权投资、推出新型发酵衍生香料、基于人工智慧的成分配方工具、推出纯素胶原蛋白以及在美国和亚洲扩建大型生物製造设施。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场挑战

第四章：关键考虑因素

  • 全球主要市场趋势
  • 主要趋势：併购、业务合作等
  • 最新技术进展
  • 永续发展洞察
  • 波特五力分析
  • 关税影响分析

第五章：全球生技原料市场分析：洞察与预测（2021-2034）

  • 主要分析结果/摘要
  • 依原料划分
    • 微生物
    • 植物
    • 动物
  • 按应用领域划分
    • 製药
    • 食品饮料
    • 个人护理及化妆品
    • 其他
  • 按地区划分
    • 北美
    • 欧洲
    • 亚太
    • 拉丁美洲
    • 中东和非洲

第六章：北美生技原料市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国各州
    • 加拿大

第七章 欧洲生技原料市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 其他欧洲国家

第八章 亚太地区生技原料市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太国家

第九章 拉丁美洲生技原料市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲生技原料市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲国家

第十一章：竞争格局

  • 市占率/排名分析：依主要公司划分（2025）
  • 公司简介
    • 奇华顿

第十二章：公司资讯

  • Codex-ing Biotech Ingredients
    • Covalo
    • dsm-firmenich
    • Abel
    • Aesthetics Rx
    • Nikko Chemicals Co., Ltd.
    • Evonik Personal Care
    • Fermenta Biotech Limited
    • Titan Biotech
    • Conagen, Inc.
    • Advanced Biotech
    • Merck KGaA

第十三章 策略建议

Product Code: FBI113927

Growth Factors of biotech ingredients Market

The global biotech ingredients market size was valued at USD 2.32 billion in 2025 and is projected to grow to USD 2.50 billion in 2026, further reaching USD 4.54 billion by 2034. The market is expanding due to increasing adoption of biotechnology-based production methods across pharmaceuticals, cosmetics, food and beverages, and agriculture. In 2025, North America dominated the market with a 45% share, supported by advanced biomanufacturing infrastructure and high R&D investments.

Biotech ingredients are produced using processes such as fermentation, enzymatic synthesis, cell culture, genetic engineering, and synthetic biology. These ingredients include enzymes, amino acids, peptides, vitamins, probiotics, and active pharmaceutical ingredients (APIs). Compared to chemically synthesized ingredients, biotech ingredients offer higher purity, sustainability, scalability, and consistency, which strengthens their adoption in regulated industries.

Market Drivers Supporting Growth

One of the major drivers is the growing demand for sustainable and clean-label ingredients across consumer and industrial sectors. In food and beverages, biotechnology-derived enzymes and probiotics help improve digestion, enhance shelf life, and meet clean-label requirements. In cosmetics, microbial-derived hyaluronic acid, peptides, and ceramides are increasingly preferred due to safety and eco-friendly sourcing.

In pharmaceuticals, biotech ingredients are critical for producing biologics, vaccines, monoclonal antibodies, and recombinant proteins. Rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders is increasing reliance on biologic therapies, directly raising demand for biotech-derived APIs and excipients.

Market Restraints Limiting Expansion

Despite strong growth prospects, high R&D and production costs remain major restraints. Developing biotech ingredients requires sophisticated laboratory facilities, skilled scientists, long development cycles, and regulatory compliance, particularly in pharmaceutical-grade production. Fermentation and cell-culture systems require precise environmental control, increasing operational costs.

Regulatory approvals further extend timelines, especially in biologics manufacturing where safety, traceability, and validation are critical. Smaller companies often face difficulty scaling production due to limited capital availability, which restricts market entry and competitiveness.

Market Opportunities from Advanced Therapies and Biosimilars

Patent expirations of blockbuster biologics have accelerated the development of biosimilars, creating strong demand for fermentation-based proteins, growth media, and purification reagents. This trend is particularly strong in oncology and autoimmune disease treatment.

Advanced therapies such as cell therapies, gene therapies, CAR-T therapies, and antibody-drug conjugates are also expanding globally. These therapies require specialized biotech ingredients, including viral vectors, recombinant cytokines, and engineered proteins, creating new long-term demand streams across regulated healthcare markets.

Market Challenges from Regulatory and Geopolitical Factors

Regulatory complexity remains a significant challenge. Approval frameworks differ across the U.S., Europe, and Asia, requiring separate documentation, testing protocols, and environmental assessments. Synthetic biology and genetically modified microbial strains often face additional scrutiny, slowing commercialization.

Geopolitical tensions and trade protectionism are also affecting ingredient supply chains. Tariffs, export controls, and dependency on Chinese and Indian raw material sourcing are forcing manufacturers to diversify production locations, increasing capital expenditure and compliance burden.

Segmentation Analysis by Source and Application

By Source

The market is segmented into animal-based, plant-based, and microbial ingredients.

Animal-based ingredients dominated in 2024, driven by high bioavailability of collagen, gelatin, and hormone-based compounds used in pharmaceuticals and nutraceuticals.

Plant-based ingredients are growing due to vegan demand and sustainability trends, supported by enzyme-assisted extraction technologies.

The microbial segment is projected to contribute about 46% globally in 2026, driven by precision fermentation, CRISPR strain optimization, and high-yield microbial synthesis.

By Application

The market is segmented into pharmaceuticals, food and beverages, personal care and cosmetics, and others.

The pharmaceuticals segment held about 45.60% share in 2026, driven by biologics, vaccines, and recombinant APIs.

Food and beverages are expanding due to rising demand for probiotics, enzymes, and functional proteins.

Personal care and cosmetics are growing due to biotech peptides, hyaluronic acid, and vegan collagen used in skin repair and anti-aging products.

The food and beverages segment accounted for approximately 15.8% share in 2024.

Regional Outlook

North America

North America recorded USD 1.06 billion in 2025 and USD 1.14 billion in 2026, remaining the largest regional market. The U.S. alone is projected to reach USD 0.90 billion by 2026, supported by biologics manufacturing and clean-label cosmetic demand.

Asia Pacific

Asia Pacific is experiencing rapid growth due to strong government funding and expanding biomanufacturing.

China is projected to reach USD 0.21 billion by 2026, India USD 0.11 billion, and Japan USD 0.05 billion, driven by pharmaceutical production and fermentation investments.

Europe

Europe benefits from sustainability regulations and strong biotech research. Germany is projected to reach USD 0.26 billion by 2026, while the UK is expected to reach USD 0.11 billion.

Latin America and Middle East & Africa

Growth is supported by expanding pharmaceutical manufacturing and rising adoption of bio-based cosmetic ingredients, especially in Brazil and Gulf countries.

Competitive Landscape and Industry Developments

Major companies include Givaudan, Codex-ing Biotech Ingredients, Covalo, dsm-firmenich, Abel, Evonik Industries, Merck KGaA, Conagen, Fermenta Biotech, and Titan Biotech. These companies focus on expanding fermentation capacity, launching sustainable ingredients, and forming strategic partnerships.

Key developments include private equity investments, new fermentation-based flavor launches, AI-driven ingredient formulation tools, vegan collagen introductions, and large-scale biomanufacturing expansions in the U.S. and Asia during 2024-2025.

Conclusion

The biotech ingredients market is showing strong structural growth, with market value increasing from USD 2.32 billion in 2025 to USD 2.50 billion in 2026 and projected to reach USD 4.54 billion by 2034, supported by rising adoption across pharmaceuticals, food and beverages, and personal care applications. North America remains the leading region, while Asia Pacific is emerging as a high-growth manufacturing and R&D hub. Expansion of biologics, biosimilars, and advanced therapies is accelerating demand for fermentation-based proteins, enzymes, and recombinant APIs, while clean-label and sustainability trends are boosting plant-based and microbial ingredient development. Although high production costs and regulatory complexity continue to challenge market participants, ongoing investments in precision fermentation, synthetic biology, and AI-driven bioprocess optimization are improving scalability and efficiency, strengthening long-term industry competitiveness and widening commercial adoption across both healthcare and consumer sectors.

Segmentation By Source

  • Microbial
  • Plant-based
  • Animal-based

By Application

  • Pharmaceuticals
  • Food and Beverages
  • Personal Care & Cosmetics
  • Others

By Region

  • North America (By Source, By Application, and By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Source, By Application, and By Country)
    • Germany (By Application)
    • France (By Application)
    • U.K. (By Application)
    • Italy (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Source, By Application, and By Country)
    • China (By Application)
    • India (By Application)
    • Japan (By Application)
    • South Korea (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Source, By Application, and By Country)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Source, By Application, and By Country)
    • Saudi Arabia (By Application)
    • South Africa (By Application)
    • Rest of Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Trends
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Market Opportunities
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Key Market Trends in the Global Market
  • 4.2. Key Developments: Mergers, Acquisitions, Partnerships, etc.
  • 4.3. Latest Technological Advancement
  • 4.4. Insights on Sustainability
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Tariff Impact Analysis

5. Global Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. By Source
    • 5.2.1. Microbial
    • 5.2.2. Plant-based
    • 5.2.3. Animal-based
  • 5.3. By Application
    • 5.3.1. Pharmaceuticals
    • 5.3.2. Food and Beverages
    • 5.3.3. Personal Care & Cosmetics
    • 5.3.4. Others
  • 5.4. By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. By Source
    • 6.2.1. Microbial
    • 6.2.2. Plant-based
    • 6.2.3. Animal-based
  • 6.3. By Application
    • 6.3.1. Pharmaceuticals
    • 6.3.2. Food and Beverages
    • 6.3.3. Personal Care & Cosmetics
    • 6.3.4. Others
  • 6.4. By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
        • 6.4.1.1.1. Pharmaceuticals
        • 6.4.1.1.2. Food and Beverages
        • 6.4.1.1.3. Personal Care & Cosmetics
        • 6.4.1.1.4. Others
    • 6.4.2. Canada
      • 6.4.2.1. By Application
        • 6.4.2.1.1. Pharmaceuticals
        • 6.4.2.1.2. Food and Beverages
        • 6.4.2.1.3. Personal Care & Cosmetics
        • 6.4.2.1.4. Others

7. Europe Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. By Source
    • 7.2.1. Microbial
    • 7.2.2. Plant-based
    • 7.2.3. Animal-based
  • 7.3. By Application
    • 7.3.1. Pharmaceuticals
    • 7.3.2. Food and Beverages
    • 7.3.3. Personal Care & Cosmetics
    • 7.3.4. Others
  • 7.4. By Country
    • 7.4.1. Germany
      • 7.4.1.1. By Application
        • 7.4.1.1.1. Pharmaceuticals
        • 7.4.1.1.2. Food and Beverages
        • 7.4.1.1.3. Personal Care & Cosmetics
        • 7.4.1.1.4. Others
    • 7.4.2. UK
      • 7.4.2.1. By Application
        • 7.4.2.1.1. Pharmaceuticals
        • 7.4.2.1.2. Food and Beverages
        • 7.4.2.1.3. Personal Care & Cosmetics
        • 7.4.2.1.4. Others
    • 7.4.3. France
      • 7.4.3.1. By Application
        • 7.4.3.1.1. Pharmaceuticals
        • 7.4.3.1.2. Food and Beverages
        • 7.4.3.1.3. Personal Care & Cosmetics
        • 7.4.3.1.4. Others
    • 7.4.4. Italy
      • 7.4.4.1. By Application
        • 7.4.4.1.1. Pharmaceuticals
        • 7.4.4.1.2. Food and Beverages
        • 7.4.4.1.3. Personal Care & Cosmetics
        • 7.4.4.1.4. Others
    • 7.4.5. Rest of Europe
      • 7.4.5.1. By Application
        • 7.4.5.1.1. Pharmaceuticals
        • 7.4.5.1.2. Food and Beverages
        • 7.4.5.1.3. Personal Care & Cosmetics
        • 7.4.5.1.4. Others

8. Asia-Pacific Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. By Source
    • 8.2.1. Microbial
    • 8.2.2. Plant-based
    • 8.2.3. Animal-based
  • 8.3. By Application
    • 8.3.1. Pharmaceuticals
    • 8.3.2. Food and Beverages
    • 8.3.3. Personal Care & Cosmetics
    • 8.3.4. Others
  • 8.4. By Country
    • 8.4.1. China
      • 8.4.1.1. By Application
        • 8.4.1.1.1. Pharmaceuticals
        • 8.4.1.1.2. Food and Beverages
        • 8.4.1.1.3. Personal Care & Cosmetics
        • 8.4.1.1.4. Others
    • 8.4.2. India
      • 8.4.2.1. By Application
        • 8.4.2.1.1. Pharmaceuticals
        • 8.4.2.1.2. Food and Beverages
        • 8.4.2.1.3. Personal Care & Cosmetics
        • 8.4.2.1.4. Others
    • 8.4.3. Japan
      • 8.4.3.1. By Application
        • 8.4.3.1.1. Pharmaceuticals
        • 8.4.3.1.2. Food and Beverages
        • 8.4.3.1.3. Personal Care & Cosmetics
        • 8.4.3.1.4. Others
    • 8.4.4. South Korea
      • 8.4.4.1. By Application
        • 8.4.4.1.1. Pharmaceuticals
        • 8.4.4.1.2. Food and Beverages
        • 8.4.4.1.3. Personal Care & Cosmetics
        • 8.4.4.1.4. Others
    • 8.4.5. Rest of Asia-Pacific
      • 8.4.5.1. By Application
        • 8.4.5.1.1. Pharmaceuticals
        • 8.4.5.1.2. Food and Beverages
        • 8.4.5.1.3. Personal Care & Cosmetics
        • 8.4.5.1.4. Others

9. Latin America Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. By Source
    • 9.2.1. Microbial
    • 9.2.2. Plant-based
    • 9.2.3. Animal-based
  • 9.3. By Application
    • 9.3.1. Pharmaceuticals
    • 9.3.2. Food and Beverages
    • 9.3.3. Personal Care & Cosmetics
    • 9.3.4. Others
  • 9.4. By Country
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
        • 9.4.1.1.1. Pharmaceuticals
        • 9.4.1.1.2. Food and Beverages
        • 9.4.1.1.3. Personal Care & Cosmetics
        • 9.4.1.1.4. Others
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
        • 9.4.2.1.1. Pharmaceuticals
        • 9.4.2.1.2. Food and Beverages
        • 9.4.2.1.3. Personal Care & Cosmetics
        • 9.4.2.1.4. Others
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application
        • 9.4.3.1.1. Pharmaceuticals
        • 9.4.3.1.2. Food and Beverages
        • 9.4.3.1.3. Personal Care & Cosmetics
        • 9.4.3.1.4. Others

10. Middle East & Africa Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. By Source
    • 10.2.1. Microbial
    • 10.2.2. Plant-based
    • 10.2.3. Animal-based
  • 10.3. By Application
    • 10.3.1. Pharmaceuticals
    • 10.3.2. Food and Beverages
    • 10.3.3. Personal Care & Cosmetics
    • 10.3.4. Others
  • 10.4. By Country
    • 10.4.1. Saudi Arabia
      • 10.4.1.1. By Application
        • 10.4.1.1.1. Pharmaceuticals
        • 10.4.1.1.2. Food and Beverages
        • 10.4.1.1.3. Personal Care & Cosmetics
        • 10.4.1.1.4. Others
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
        • 10.4.2.1.1. Pharmaceuticals
        • 10.4.2.1.2. Food and Beverages
        • 10.4.2.1.3. Personal Care & Cosmetics
        • 10.4.2.1.4. Others
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application
        • 10.4.3.1.1. Pharmaceuticals
        • 10.4.3.1.2. Food and Beverages
        • 10.4.3.1.3. Personal Care & Cosmetics
        • 10.4.3.1.4. Others

11. Competitive Landscape

  • 11.1. Company Market Share/Ranking Analysis, By Key Players, 2025
  • 11.2. Company Profiles
    • 11.2.1. Givaudan
      • 11.2.1.1. Overview
      • 11.2.1.2. Description
      • 11.2.1.3. Product Portfolio
      • 11.2.1.4. Financials (Data as available in the public domain and/or on paid databases)
      • 11.2.1.5. Recent Developments

12. Similar information has been provided for all the below companies

  • 12.1. Codex-ing Biotech Ingredients
    • 12.1.1. Covalo
    • 12.1.2. dsm-firmenich.
    • 12.1.3. Abel
    • 12.1.4. Aesthetics Rx
    • 12.1.5. Nikko Chemicals Co., Ltd.
    • 12.1.6. Evonik Personal Care
    • 12.1.7. Fermenta Biotech Limited
    • 12.1.8. Titan Biotech.
    • 12.1.9. Conagen, Inc.
    • 12.1.10. Advanced Biotech
    • 12.1.11. Merck KGaA

13. Strategic Recommendations

List of Tables

  • Table 1: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 2: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 3: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Region, 2021-2034
  • Table 4: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 5: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 6: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 7: U.S. Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 8: Canada Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 9: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 10: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 12: Germany Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 13: France Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 14: UK Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 15: Italy Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 16: Rest of Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 17: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 18: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 19: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 20: China Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 21: India Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 22: Japan Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 23: South Korea Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 24: Rest of Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 25: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 26: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 27: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 28: Brazil Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 29: Mexico Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 30: Rest of Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 31: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 32: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 33: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 34: Saudi Arabia Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 35: South Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 36: Rest of Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 1: Global Biotech Ingredients Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 2: Global Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 3: Global Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 4: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Microbial, 2021-2034
  • Figure 5: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Plant-based, 2021-2034
  • Figure 6: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Animal-based, 2021-2034
  • Figure 7: Global Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 8: Global Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 9: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Pharmaceuticals, 2021-32
  • Figure 10: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Food and Beverages, 2021-2034
  • Figure 11: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Personal Care & Cosmetics, 2021-32
  • Figure 12: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Others, 2021-32
  • Figure 13: Global Biotech Ingredients Market Revenue (USD Billion), by Region, 2025 & 2034
  • Figure 14: Global Biotech Ingredients Market Revenue Share (%), by Region, 2025
  • Figure 15: North America Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 16: North America Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 17: North America Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 18: North America Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 19: North America Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 20: North America Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 21: Europe Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 22: Europe Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 23: Europe Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 24: Europe Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 25: Europe Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 26: Europe Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 27: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 28: Asia Pacific Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 29: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 30: Asia Pacific Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 31: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 32: Asia Pacific Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 33: Latin America Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 34: Latin America Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 35: Latin America Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 36: Latin America Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 37: Latin America Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 38: Latin America Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 39: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 40: Middle East & Africa Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 41: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 42: Middle East & Africa Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 43: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 44: Middle East & Africa Biotech Ingredients Market Revenue Share (%), by Country, 2025